Tenascin-C: Form versus function

References

• Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.org/10.1007/s12079-009-0075-1
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS. Tenascins in stem cell niches. Matrix Biol 2014; 37C:112-23; http://dx.doi.org/10.1016/j.matbio.2014.01.007
   Web of Science ®Google Scholar
• Orend G, Saupe F, Schwenzer A, and Midwood, KS. The extracellular matrix and cancer: regulation of tumor cell biology by tenascin-C. iConcept Press 2014. ISBN: 978-1-922227-25-6.
   Google Scholar
• Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Nat Acad Sci USA 1996; 93:6594-9; PMID:8692862; http://dx.doi.org/10.1073/pnas.93.13.6594
   PubMed Web of Science ®Google Scholar
• Fukamauchi F, Wang YJ, Mataga N, Kusakabe M. Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice. Neuroreport 1997; 8:3919-22; PMID:9462466; http://dx.doi.org/10.1097/00001756-199712220-00015
   PubMedGoogle Scholar
• Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol 1998; 152:1237-45; PMID:9588892
   PubMed Web of Science ®Google Scholar
• Ohta M, Sakai T, Saga Y, Aizawa S, Saito M. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 1998; 91:4074-83; PMID:9596652
   PubMed Web of Science ®Google Scholar
• Talts JF, Wirl G, Dictor M, Muller WJ, Fassler R. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J Cell Sci 1999; 112(Pt 12):1855-64; PMID:10341205
   PubMed Web of Science ®Google Scholar
• Van Obberghen-Schilling E, Tucker RP, Saupe F, Gasser I, Cseh B, Orend G. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 2011; 55:511-25; PMID:21769776; http://dx.doi.org/10.1387/ijdb.103243eo
   PubMedGoogle Scholar
• Saupe F, Schwenzer A, Jia Y, Gasser I, Spenle C, Langlois B, Kammerer M, Lefebvre O, Hlushchuk R, Rupp T, et al. Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model. Cell Rep 2013; 5:482-92; PMID:24139798; http://dx.doi.org/10.1016/j.celrep.2013.09.014
   PubMedGoogle Scholar
• Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009; 15:774-80; PMID:19561617; http://dx.doi.org/10.1038/nm.1987
   PubMed Web of Science ®Google Scholar
• El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, Imanaka-Yoshida K. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol 2007; 211:86-94; PMID:17121418; http://dx.doi.org/10.1002/path.2099
   PubMed Web of Science ®Google Scholar
• Nakahara H, Gabazza EC, Fujimoto H, Nishii Y, D'Alessandro-Gabazza CN, Bruno NE, Takagi T, Hayashi T, Maruyama J, Maruyama K, et al. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur J Immunol 2006; 36:3334-45; PMID:17125141; http://dx.doi.org/10.1002/eji.200636271
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Tucker RP. Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol 2011; 3(5).
   Google Scholar
• Mackie EJ, Tucker RP. The tenascin-C knockout revisited. J Cell Sci 1999; 112(Pt 22):3847-53; PMID:10547346
   PubMed Web of Science ®Google Scholar
• Mokone GG, Gajjar M, September AV, Schwellnus MP, Greenberg J, Noakes TD, Collins M. The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries. Am J Sports Med 2005; 33:1016-21; PMID:15983124; http://dx.doi.org/10.1177/0363546504271986
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao F, Zong L, Zhang P, Guan L, Zhang J, Wang D, Wang J, Chai W, Lan L, et al. Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss. PloS One 2013; 8:e69549; PMID:23936043; http://dx.doi.org/10.1371/journal.pone.0069549
   PubMedGoogle Scholar
• Matsuda A, Hirota T, Akahoshi M, Shimizu M, Tamari M, Miyatake A, Takahashi A, Nakashima K, Takahashi N, Obara K, et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 2005; 14:2779-86; PMID:16115819; http://dx.doi.org/10.1093/hmg/ddi311
   PubMedGoogle Scholar
• Gulcher JR, Alexakos MJ, Le Beau MM, Lemons RS, Stefansson K. Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. Genomics 1990; 6:616-22; PMID:1692804; http://dx.doi.org/10.1016/0888-7543(90)90495-G
   PubMed Web of Science ®Google Scholar
• Rocchi M, Archidiacono N, Romeo G, Saginati M, Zardi L. Assignment of the gene for human tenascin to the region q32-q34 of chromosome 9. Hum Genet 1991; 86:621-3; PMID:1709136
   PubMed Web of Science ®Google Scholar
• Udalova IA, Ruhmann M, Thomson SJ, Midwood KS. Expression and immune function of tenascin-C. Crit Rev Immunol 2011; 31:115-45; PMID:21542790; http://dx.doi.org/10.1615/CritRevImmunol.v31.i2.30
   PubMed Web of Science ®Google Scholar
• Jones FS, Burgoon MP, Hoffman S, Crossin KL, Cunningham BA, Edelman GM. A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Nat Acad Sci U S A 1988; 85:2186-90; PMID:2451243; http://dx.doi.org/10.1073/pnas.85.7.2186
   PubMed Web of Science ®Google Scholar
• Gulcher JR, Nies DE, Marton LS, Stefansson K. An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Nat Acad Sci U S A 1989; 86:1588-92; PMID:2466295; http://dx.doi.org/10.1073/pnas.86.5.1588
   PubMed Web of Science ®Google Scholar
• Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000; 218:235-59; PMID:10842355; http://dx.doi.org/10.1002/(SICI)1097-0177(200006)218:2%3c235::AID-DVDY2%3e3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40:1413-5; PMID:18978789; http://dx.doi.org/10.1038/ng.259
   PubMed Web of Science ®Google Scholar
• Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madugundu AK, Kelkar DS, Isserlin R, Jain S, et al. A draft map of the human proteome. Nature 2014; 509:575-81; PMID:24870542; http://dx.doi.org/10.1038/nature13302
   PubMed Web of Science ®Google Scholar
• Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 1993; 21:163-8; PMID:7680113; http://dx.doi.org/10.1093/nar/21.1.163
   PubMed Web of Science ®Google Scholar
• Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 1997; 72:236-40; PMID:9219826; http://dx.doi.org/10.1002/(SICI)1097-0215(19970717)72:2%3c236::AID-IJC6%3e3.0.CO;2-S
   PubMedGoogle Scholar
• Tucker RP, Spring J, Baumgartner S, Martin D, Hagios C, Poss PM, Chiquet-Ehrismann R. Novel tenascin variants with a distinctive pattern of expression in the avian embryo. Development 1994; 120:637-47; PMID:7512896
   PubMed Web of Science ®Google Scholar
• Gulcher JR, Nies DE, Alexakos MJ, Ravikant NA, Sturgill ME, Marton LS, Stefansson K. Structure of the human hexabrachion (tenascin) gene. Proc Nat Acad Sci U S A 1991; 88:9438-42; PMID:1719530; http://dx.doi.org/10.1073/pnas.88.21.9438
   PubMedGoogle Scholar
• Joester A, Faissner A. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J Biol Chem 1999; 274:17144-51; PMID:10358070; http://dx.doi.org/10.1074/jbc.274.24.17144
   PubMedGoogle Scholar
• Garwood J, Theocharidis U, Calco V, Dobbertin A, Faissner A. Existence of tenascin-C isoforms in rat that contain the alternatively spliced AD1 domain are developmentally regulated during hippocampal development. Cell Mol Neurobiol 2012; 32:279-87; PMID:21968644; http://dx.doi.org/10.1007/s10571-011-9759-1
   PubMedGoogle Scholar
• Joester A, Faissner A. The structure and function of tenascins in the nervous system. Matrix Biol 2001; 20:13-22; PMID:11246000; http://dx.doi.org/10.1016/S0945-053X(00)00136-0
   PubMedGoogle Scholar
• Saga Y, Tsukamoto T, Jing N, Kusakabe M, Sakakura T. Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. Gene 1991; 104:177-85; PMID:1717349; http://dx.doi.org/10.1016/0378-1119(91)90248-A
   PubMed Web of Science ®Google Scholar
• Ocklind G, Talts J, Fassler R, Mattsson A, Ekblom P. Expression of tenascin in developing and adult mouse lymphoid organs. J Histochem Cytochem 1993; 41:1163-9; PMID:7687262; http://dx.doi.org/10.1177/41.8.7687262
   PubMedGoogle Scholar
• Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47:131-9; PMID:2428505; http://dx.doi.org/10.1016/0092-8674(86)90374-0
   PubMed Web of Science ®Google Scholar
• Chiquet M, Vrucinic-Filipi N, Schenk S, Beck K, Chiquet-Ehrismann R. Isolation of chick tenascin variants and fragments. A C-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant. Eur J Biochem 1991; 199:379-88; PMID:1712728
   PubMedGoogle Scholar
• Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 1989; 59:325-34; PMID:2478295; http://dx.doi.org/10.1016/0092-8674(89)90294-8
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Matsuoka Y, Hofer U, Spring J, Bernasconi C, Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 1991; 2:927-38; PMID:1725601
   PubMedGoogle Scholar
• Weller A, Beck S, Ekblom P. Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J Cell Biol 1991; 112:355-62; PMID:1703162; http://dx.doi.org/10.1083/jcb.112.2.355
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 1984; 98:1926-36; PMID:6725406; http://dx.doi.org/10.1083/jcb.98.6.1926
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol 1984; 98:1937-46; PMID:6202699; http://dx.doi.org/10.1083/jcb.98.6.1937
   PubMed Web of Science ®Google Scholar
• Hoffman S, Crossin KL, Edelman GM. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J Cell Biol 1988; 106:519-32; PMID:2448317; http://dx.doi.org/10.1083/jcb.106.2.519
   PubMed Web of Science ®Google Scholar
• Prieto AL, Jones FS, Cunningham BA, Crossin KL, Edelman GM. Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J Cell Biol 1990; 111:685-98; PMID:1696267; http://dx.doi.org/10.1083/jcb.111.2.685
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Tucker RP. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci 1992; 103(Pt 3):765-71; PMID:1282516
   PubMed Web of Science ®Google Scholar
• Tucker RP. The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 1993; 117:347-58; PMID:7693413
   PubMed Web of Science ®Google Scholar
• Tucker RP, Hammarback JA, Jenrath DA, Mackie EJ, Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 1993; 104(Pt 1):69-76; PMID:7680659
   PubMed Web of Science ®Google Scholar
• Tucker RP, McKay SE. The expression of tenascin by neural crest cells and glia. Development 1991; 112:1031-9; PMID:1718677
   PubMed Web of Science ®Google Scholar
• Derr LB, Chiquet-Ehrismann R, Gandour-Edwards R, Spence J, Tucker RP. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation 1997; 62:71-82; PMID:9404002; http://dx.doi.org/10.1046/j.1432-0436.1997.6220071.x
   PubMedGoogle Scholar
• Kaplony A, Zimmermann DR, Fischer RW, Imhof BA, Odermatt BF, Winterhalter KH, Vaughan L. Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. Development 1991; 112:605-14; PMID:1724418
   PubMed Web of Science ®Google Scholar
• Pacifici M, Iwamoto M, Golden EB, Leatherman JL, Lee YS, Chuong CM. Tenascin is associated with articular cartilage development. Dev Dyn 1993; 198:123-34; PMID:7508293; http://dx.doi.org/10.1002/aja.1001980206
   PubMed Web of Science ®Google Scholar
• Anstrom KK, Tucker RP. Tenascin-C lines the migratory pathways of avian primordial germ cells and hematopoietic progenitor cells. Dev Dyn 1996; 206:437-46; PMID:8853992; http://dx.doi.org/10.1002/(SICI)1097-0177(199608)206:4%3c437::AID-AJA9%3e3.0.CO;2-J
   PubMedGoogle Scholar
• Aufderheide E, Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J Cell Biol 1988; 107:2341-9; PMID:2461951; http://dx.doi.org/10.1083/jcb.107.6.2341
   PubMed Web of Science ®Google Scholar
• Young SL, Chang LY, Erickson HP. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol 1994; 161:615-25; PMID:7508872; http://dx.doi.org/10.1006/dbio.1994.1057
   PubMed Web of Science ®Google Scholar
• Zhao Y, Young SL. TGF-β regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am J Physiol 1995; 268:L173-80; PMID:7532367
   PubMed Web of Science ®Google Scholar
• Dorries U, Schachner M. Tenascin mRNA isoforms in the developing mouse brain. J Neurosci Res 1994; 37:336-47; PMID:7513764; http://dx.doi.org/10.1002/jnr.490370306
   PubMedGoogle Scholar
• Bartsch S, Bartsch U, Dorries U, Faissner A, Weller A, Ekblom P, Schachner M. Expression of tenascin in the developing and adult cerebellar cortex. J Neurosci 1992; 12:736-49; PMID:1372043
   PubMed Web of Science ®Google Scholar
• Zisch AH, D'Alessandri L, Ranscht B, Falchetto R, Winterhalter KH, Vaughan L. Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains. J Cell Biol 1992; 119:203-13; PMID:1382076; http://dx.doi.org/10.1083/jcb.119.1.203
   PubMed Web of Science ®Google Scholar
• Vaughan L, Weber P, D'Alessandri L, Zisch AH, Winterhalter KH. Tenascin-contactin/F11 interactions: a clue for a developmental role? Perspect Dev Neurobiol 1994; 2:43-52; PMID:7530143
   PubMedGoogle Scholar
• Weber P, Ferber P, Fischer R, Winterhalter KH, Vaughan L. Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin. FEBS Lett 1996; 389:304-8; PMID:8766721; http://dx.doi.org/10.1016/0014-5793(96)00609-6
   PubMedGoogle Scholar
• Ghert MA, Qi WN, Erickson HP, Block JA, Scully SP. Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. Cell Struct Funct 2001; 26:179-87; PMID:11565810; http://dx.doi.org/10.1247/csf.26.179
   PubMedGoogle Scholar
• Crossin KL, Hoffman S, Tan SS, Edelman GM. Cytotactin and its proteoglycan ligand mark structural and functional boundaries in somatosensory cortex of the early postnatal mouse. Dev Biol 1989; 136:381-92; PMID:2479585; http://dx.doi.org/10.1016/0012-1606(89)90264-9
   PubMed Web of Science ®Google Scholar
• Steindler DA, Cooper NG, Faissner A, Schachner M. Boundaries defined by adhesion molecules during development of the cerebral cortex: the J1/tenascin glycoprotein in the mouse somatosensory cortical barrel field. Dev Biol 1989; 131:243-60; PMID:2462518; http://dx.doi.org/10.1016/S0012-1606(89)80056-9
   PubMed Web of Science ®Google Scholar
• Meiners S, Geller HM. Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol and Cell Neurosci 1997; 10:100-16; PMID:9361291; http://dx.doi.org/10.1006/mcne.1997.0643
   PubMedGoogle Scholar
• Garcion E, Faissner A, ffrench-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 2001; 128:2485-96; PMID:11493565
   PubMed Web of Science ®Google Scholar
• Gates MA, Thomas LB, Howard EM, Laywell ED, Sajin B, Faissner A, Gotz B, Silver J, Steindler DA. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J Comp Neurol 1995; 361:249-66; PMID:8543661; http://dx.doi.org/10.1002/cne.903610205
   PubMedGoogle Scholar
• Treloar HB, Ray A, Dinglasan LA, Schachner M, Greer CA. Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J Neurosci 2009; 29:9405-16; PMID:19641104; http://dx.doi.org/10.1523/JNEUROSCI.2356-09.2009
   PubMedGoogle Scholar
• Garcion E, Halilagic A, Faissner A, ffrench-Constant C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 2004; 131:3423-32; PMID:15226258; http://dx.doi.org/10.1242/dev.01202
   PubMed Web of Science ®Google Scholar
• von Holst A, Egbers U, Prochiantz A, Faissner A. Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6. J Biol Chem 2007; 282:9172-81; PMID:17264084; http://dx.doi.org/10.1074/jbc.M608067200
   PubMedGoogle Scholar
• Moritz S, Lehmann S, Faissner A, von Holst A. An induction gene trap screen in neural stem cells reveals an instructive function of the niche and identifies the splicing regulator sam68 as a tenascin-C-regulated target gene. Stem Cells 2008; 26:2321-31; PMID:18617690; http://dx.doi.org/10.1634/stemcells.2007-1095
   PubMedGoogle Scholar
• Yagi H, Yanagisawa M, Suzuki Y, Nakatani Y, Ariga T, Kato K, Yu RK. HNK-1 epitope-carrying tenascin-C spliced variant regulates the proliferation of mouse embryonic neural stem cells. J Biol Chem 2010; 285:37293-301; PMID:20855890; http://dx.doi.org/10.1074/jbc.M110.157081
   PubMedGoogle Scholar
• Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M. The J1 glycoprotein–a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature 1985; 316:146-8; PMID:2409452; http://dx.doi.org/10.1038/316146a0
   PubMed Web of Science ®Google Scholar
• McGarry RC, Helfand SL, Quarles RH, Roder JC. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature 1983; 306:376-8; PMID:6196641; http://dx.doi.org/10.1038/306376a0
   PubMedGoogle Scholar
• Kruse J, Mailhammer R, Wernecke H, Faissner A, Sommer I, Goridis C, Schachner M. Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature 1984; 311:153-5; PMID:6206400; http://dx.doi.org/10.1038/311153a0
   PubMed Web of Science ®Google Scholar
• Nieke J, Schachner M. Expression of the neural cell adhesion molecules L1 and N-CAM and their common carbohydrate epitope L2/HNK-1 during development and after transection of the mouse sciatic nerve. Differentiation 1985; 30:141-51; PMID:2420673; http://dx.doi.org/10.1111/j.1432-0436.1985.tb00525.x
   PubMed Web of Science ®Google Scholar
• Gotz B, Scholze A, Clement A, Joester A, Schutte K, Wigger F, Frank R, Spiess E, Ekblom P, Faissner A. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol 1996; 132:681-99; PMID:8647898; http://dx.doi.org/10.1083/jcb.132.4.681
   PubMedGoogle Scholar
• Husmann K, Faissner A, Schachner M. Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J Cell Biol 1992; 116:1475-86; PMID:1371773; http://dx.doi.org/10.1083/jcb.116.6.1475
   PubMed Web of Science ®Google Scholar
• Mercado ML, Nur-e-Kamal A, Liu HY, Gross SR, Movahed R, Meiners S. Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal alpha7beta1 integrin. J Neurosci 2004; 24:238-47; PMID:14715956; http://dx.doi.org/10.1523/JNEUROSCI.4519-03.2004
   PubMed Web of Science ®Google Scholar
• Gotz M, Bolz J, Joester A, Faissner A. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur J Neurosci 1997; 9:496-506; PMID:9104592; http://dx.doi.org/10.1111/j.1460-9568.1997.tb01627.x
   PubMedGoogle Scholar
• Sahlberg C, Aukhil I, Thesleff I. Tenascin-C in developing mouse teeth: expression of splice variants and stimulation by TGFbeta and FGF. Eur J Oral Sci 2001; 109:114-24; PMID:11347655; http://dx.doi.org/10.1034/j.1600-0722.2001.00990.x
   PubMedGoogle Scholar
• Jones PL, Boudreau N, Myers CA, Erickson HP, Bissell MJ. Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments. J Cell Sci 1995; 108(Pt 2):519-27; PMID:7539436
   PubMed Web of Science ®Google Scholar
• Wehrle B, Chiquet M. Tenascin is accumulated along developing peripheral nerves and allows neurite outgrowth in vitro. Development 1990; 110:401-15; PMID:1723942
   PubMed Web of Science ®Google Scholar
• Perez RG, Halfter W. Tenascin in the developing chick visual system: distribution and potential role as a modulator of retinal axon growth. Dev Biol 1993; 156:278-92; PMID:7680630; http://dx.doi.org/10.1006/dbio.1993.1076
   PubMed Web of Science ®Google Scholar
• Bartsch S, Husmann K, Schachner M, Bartsch U. The extracellular matrix molecule tenascin: expression in the developing chick retinotectal system and substrate properties for retinal ganglion cell neurites in vitro. Eur J Neurosci 1995; 7:907-16; PMID:7542126; http://dx.doi.org/10.1111/j.1460-9568.1995.tb01078.x
   PubMedGoogle Scholar
• Phillips GR, Edelman GM, Crossin KL. Separate cell binding sites within cytotactin/tenascin differentially promote neurite outgrowth. Cell Adhes Commun 1995; 3:257-71; PMID:8846026; http://dx.doi.org/10.3109/15419069509081291
   PubMed Web of Science ®Google Scholar
• Fischer D, Tucker RP, Chiquet-Ehrismann R, Adams JC. Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol Biol Cell 1997; 8:2055-75; PMID:9348542; http://dx.doi.org/10.1091/mbc.8.10.2055
   PubMedGoogle Scholar
• Adams JC, Lawler J. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell 1994; 5:423-37; PMID:7519904; http://dx.doi.org/10.1091/mbc.5.4.423
   PubMed Web of Science ®Google Scholar
• Chung CY, Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 1994; 126:539-48; PMID:7518469; http://dx.doi.org/10.1083/jcb.126.2.539
   PubMed Web of Science ®Google Scholar
• Chung CY, Murphy-Ullrich JE, Erickson HP. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 1996; 7:883-92; PMID:8816995; http://dx.doi.org/10.1091/mbc.7.6.883
   PubMedGoogle Scholar
• Meiners S, Mercado ML, Nur-e-Kamal MS, Geller HM. Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. J Neurosci 1999; 19:8443-53; PMID:10493745
   PubMed Web of Science ®Google Scholar
• Rigato F, Garwood J, Calco V, Heck N, Faivre-Sarrailh C, Faissner A. Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin. J Neurosci 2002; 22:6596-609; PMID:12151539
   PubMed Web of Science ®Google Scholar
• Lochter A, Vaughan L, Kaplony A, Prochiantz A, Schachner M, Faissner A. J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J Cell Biol 1991; 113:1159-71; PMID:1710226; http://dx.doi.org/10.1083/jcb.113.5.1159
   PubMed Web of Science ®Google Scholar
• Meiners S, Powell EM, Geller HM. Neurite outgrowth promotion by the alternatively spliced region of tenascin-C is influenced by cell-type specific binding. Matrix Biol 1999; 18:75-87; PMID:10367733; http://dx.doi.org/10.1016/S0945-053X(98)00008-0
   PubMedGoogle Scholar
• Siddiqui S, Horvat-Brocker A, Faissner A. The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD. Neuron Glia Biol 2008; 4:271-83; PMID:19508743; http://dx.doi.org/10.1017/S1740925X09990020
   PubMedGoogle Scholar
• Michele M, Faissner A. Tenascin-C stimulates contactin-dependent neurite outgrowth via activation of phospholipase C. Mol and Cell Neurosci 2009; 41:397-408; PMID:19394429; http://dx.doi.org/10.1016/j.mcn.2009.04.004
   PubMedGoogle Scholar
• Bell SC, Pringle JH, Taylor DJ, Malak TM. Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes. Mol Hum Reprod 1999; 5:1066-76; PMID:10541570; http://dx.doi.org/10.1093/molehr/5.11.1066
   PubMedGoogle Scholar
• Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 1995; 270:8650-4; PMID:7536739; http://dx.doi.org/10.1074/jbc.270.15.8650
   PubMed Web of Science ®Google Scholar
• Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett 2006; 244:143-63; PMID:16632194; http://dx.doi.org/10.1016/j.canlet.2006.02.017
   PubMed Web of Science ®Google Scholar
• Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 1990; 63:798-806; PMID:1701508
   PubMed Web of Science ®Google Scholar
• Borsi L, Carnemolla B, Nicolo G, Spina B, Tanara G, Zardi L. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 1992; 52:688-92; PMID:1385335; http://dx.doi.org/10.1002/ijc.2910520504
   PubMed Web of Science ®Google Scholar
• Oyama F, Hirohashi S, Shimosato Y, Titani K, Sekiguchi K. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res 1991; 51:4876-81; PMID:1716516
   PubMed Web of Science ®Google Scholar
• Lohi J, Tani T, Laitinen L, Kangas L, Lehto VP, Virtanen I. Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice. Int J Cancer 1995; 63:442-9; PMID:7591246; http://dx.doi.org/10.1002/ijc.2910630324
   PubMedGoogle Scholar
• Sakai T, Kawakatsu H, Hirota N, Yokoyama T, Sakakura T, Saito M. Specific expression of tenascin in human colonic neoplasms. Br J Cancer 1993; 67:1058-64; PMID:7684238; http://dx.doi.org/10.1038/bjc.1993.194
   PubMedGoogle Scholar
• Parekh K, Ramachandran S, Cooper J, Bigner D, Patterson A, Mohanakumar T. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes. Lung Cancer 2005; 47:17-29; PMID:15603851; http://dx.doi.org/10.1016/j.lungcan.2004.05.016
   PubMedGoogle Scholar
• Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L, Castellucci M, Klosterhalfen B, Hartung P, Weis J, Stocker G, et al. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest 1995; 73:172-82; PMID:7543628
   PubMed Web of Science ®Google Scholar
• Zirbes TK, Baldus SE, Moenig SP, Schmitz K, Thiele J, Holscher AH, Dienes HP. Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications. Int J Mol Med 1999; 4:39-42; PMID:10373635
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Mori M, Kajiyama K, Haraguchi Y, Sasaki O, Sugimachi K. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes. Br J Cancer 1995; 72:189-92; PMID:7541237; http://dx.doi.org/10.1038/bjc.1995.301
   PubMed Web of Science ®Google Scholar
• Ilunga K, Iriyama K. Expression of tenascin in gastric carcinoma. Br J Surg 1995; 82:948-51; PMID:7544220; http://dx.doi.org/10.1002/bjs.1800820730
   PubMed Web of Science ®Google Scholar
• Atula T, Hedstrom J, Finne P, Leivo I, Markkanen-Leppanen M, Haglund C. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res 2003; 23:3051-6; PMID:12926160
   PubMed Web of Science ®Google Scholar
• Juuti A, Nordling S, Louhimo J, Lundin J, Haglund C. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation. J Clin Pathol 2004; 57:1151-5; PMID:15509674; http://dx.doi.org/10.1136/jcp.2003.015818
   PubMed Web of Science ®Google Scholar
• Pilch H, Schaffer U, Schlenger K, Lautz A, Tanner B, Hockel M, Knapstein PG. Expression of tenascin in human cervical cancer–association of tenascin expression with clinicopathological parameters. Gynecol Oncol 1999; 73:415-21; PMID:10366470; http://dx.doi.org/10.1006/gyno.1999.5405
   PubMedGoogle Scholar
• Moch H, Torhorst J, Durmuller U, Feichter GE, Sauter G, Gudat F. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Pathol Res Pract 1993; 189:510-4; PMID:7690952; http://dx.doi.org/10.1016/S0344-0338(11)80357-2
   PubMed Web of Science ®Google Scholar
• Sugawara I, Hirakoshi J, Masunaga A, Itoyama S, Sakakura T. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis. Invasion Metastasis 1991; 11:325-31; PMID:1726610
   PubMedGoogle Scholar
• Hindermann W, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D, Kosmehl H. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 1999; 189:475-80; PMID:10629546; http://dx.doi.org/10.1002/(SICI)1096-9896(199912)189:4%3c475::AID-PATH462%3e3.0.CO;2-V
   PubMedGoogle Scholar
• Katenkamp K, Berndt A, Hindermann W, Wunderlich H, Haas KM, Borsi L, Zardi L, Kosmehl H. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma. J Pathol 2004; 203:771-9; PMID:15221936; http://dx.doi.org/10.1002/path.1589
   PubMedGoogle Scholar
• Carnemolla B, Castellani P, Ponassi M, Borsi L, Urbini S, Nicolo G, Dorcaratto A, Viale G, Winter G, Neri D, et al. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol 1999; 154:1345-52; PMID:10329587; http://dx.doi.org/10.1016/S0002-9440(10)65388-6
   PubMed Web of Science ®Google Scholar
• Viale GL, Castellani P, Dorcaratto A, Pau A, Sehrbundt E, Siri A, Biro A, Zardi L. Occurrence of a glioblastoma-associated tenascin-C isoform in cerebral cavernomas and neighboring vessels. Neurosurgery 2002; 50:838-42; discussion 42; PMID:11904036; http://dx.doi.org/10.1097/00006123-200204000-00028
   PubMedGoogle Scholar
• Silacci M, Brack SS, Spath N, Buck A, Hillinger S, Arni S, Weder W, Zardi L, Neri D. Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 2006; 19:471-8; PMID:16928692; http://dx.doi.org/10.1093/protein/gzl033
   PubMed Web of Science ®Google Scholar
• Franz M, Hansen T, Borsi L, Geier C, Hyckel P, Schleier P, Richter P, Altendorf-Hofmann A, Kosmehl H, Berndt A. A quantitative co-localization analysis of large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy. J Oral Pathol Med 2007; 36:6-11; PMID:17181735; http://dx.doi.org/10.1111/j.1600-0714.2006.00492.x
   PubMedGoogle Scholar
• Berndt A, Anger K, Richter P, Borsi L, Brack S, Silacci M, Franz M, Wunderlich H, Gajda M, Zardi L, et al. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. J Cancer Res Clin Oncol 2006; 132:537-46; PMID:16788848; http://dx.doi.org/10.1007/s00432-006-0106-8
   PubMedGoogle Scholar
• Adams M, Jones JL, Walker RA, Pringle JH, Bell SC. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 2002; 62:3289-97; PMID:12036947
   PubMed Web of Science ®Google Scholar
• Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 2003; 162:1857-67; PMID:12759243; http://dx.doi.org/10.1016/S0002-9440(10)64320-9
   PubMed Web of Science ®Google Scholar
• Guttery DS, Hancox RA, Mulligan KT, Hughes S, Lambe SM, Pringle JH, Walker RA, Jones JL, Shaw JA. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res 2010; 12:R57; PMID:20678196
   PubMed Web of Science ®Google Scholar
• Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev 2010; 29:595-606; PMID:20814719; http://dx.doi.org/10.1007/s10555-010-9249-9
   PubMed Web of Science ®Google Scholar
• Dueck M, Riedl S, Hinz U, Tandara A, Moller P, Herfarth C, Faissner A. Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. Int J Cancer 1999; 82:477-83; PMID:10404058; http://dx.doi.org/10.1002/(SICI)1097-0215(19990812)82:4%3c477::AID-IJC2%3e3.0.CO;2-5
   PubMedGoogle Scholar
• Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H. High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig 2007; 11:93-9; PMID:17111122; http://dx.doi.org/10.1007/s00784-006-0086-8
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991; 115:1127-36; PMID:1720121; http://dx.doi.org/10.1083/jcb.115.4.1127
   PubMed Web of Science ®Google Scholar
• Galoian KA, Garamszegi N, Garamszegi SP, Scully SP. Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential. Exp Biol Med 2007; 232:515-22; PMID:17392487
   PubMed Web of Science ®Google Scholar
• Chung CY, Zardi L, Erickson HP. Binding of tenascin-C to soluble fibronectin and matrix fibrils. J Biol Chem 1995; 270:29012-7; PMID:7499434; http://dx.doi.org/10.1074/jbc.270.48.29012
   PubMedGoogle Scholar
• Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA, Pringle JH, Jones JL. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res: BCR 2009; 11:R24; PMID:19405959
   PubMed Web of Science ®Google Scholar
• Tucker RP. Quantitative in situ localization of tenascin-C alternatively spliced transcripts in the avian optic tectum. Mol Vis 1998; 4:18; PMID:9756954
   PubMedGoogle Scholar
• Saito Y, Imazeki H, Miura S, Yoshimura T, Okutsu H, Harada Y, Ohwaki T, Nagao O, Kamiya S, Hayashi R, et al. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem 2007; 282:34929-37; PMID:17901052; http://dx.doi.org/10.1074/jbc.M705608200
   PubMed Web of Science ®Google Scholar
• Cai M, Onoda K, Takao M, Kyoko IY, Shimpo H, Yoshida T, Yada I. Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer. Clin Cancer Res 2002; 8:1152-6; PMID:11948127
   PubMed Web of Science ®Google Scholar
• Tanaka R, Seki Y, Saito Y, Kamiya S, Fujita M, Okutsu H, Iyoda T, Takai T, Owaki T, Yajima H, et al. Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin alpha5beta1. J Biol Chem 2014; 289:17699-708; PMID:24808173; http://dx.doi.org/10.1074/jbc.M113.546622
   PubMedGoogle Scholar
• Gong XG, Lv YF, Li XQ, Xu FG, Ma QY. Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. Biol Pharm Bull 2010; 33:1261-7; PMID:20686216; http://dx.doi.org/10.1248/bpb.33.1261
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang N, Hadden TJ, Rishi AK. Akt, FoxO and regulation of apoptosis. Biochimi Biophys Acta 2011; 1813:1978-86; PMID:21440011; http://dx.doi.org/10.1016/j.bbamcr.2011.03.010
   PubMed Web of Science ®Google Scholar
• Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, et al. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 2006; 208:673-85; PMID:16450333; http://dx.doi.org/10.1002/path.1935
   PubMed Web of Science ®Google Scholar
• Riedl S, Bodenmuller H, Hinz U, Holle R, Moller P, Schlag P, Herfarth C, Faissner A. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer 1995; 64:65-9; PMID:7545144; http://dx.doi.org/10.1002/ijc.2910640113
   PubMedGoogle Scholar
• Riedl S, Tandara A, Reinshagen M, Hinz U, Faissner A, Bodenmuller H, Buhr HJ, Herfarth C, Moller P. Serum tenascin-C is an indicator of inflammatory bowel disease activity. Int J Colorectal Dis 2001; 16:285-91; PMID:11686525; http://dx.doi.org/10.1007/s003840100312
   PubMedGoogle Scholar
• Burchardt ER, Hein R, Bosserhoff AK. Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 2003; 28:515-20; PMID:12950343; http://dx.doi.org/10.1046/j.1365-2230.2003.01326.x
   PubMedGoogle Scholar
• Schenk S, Bruckner-Tuderman L, Chiquet-Ehrismann R. Dermo-epidermal separation is associated with induced tenascin expression in human skin. Br J Dermatol 1995; 133:13-22; PMID:7545419; http://dx.doi.org/10.1111/j.1365-2133.1995.tb02486.x
   PubMedGoogle Scholar
• Ishiwata T, Takahashi K, Shimanuki Y, Ohashi R, Cui R, Takahashi F, Shimizu K, Miura K, Fukuchi Y. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. Anticancer Res 2005; 25:489-95; PMID:15816617
   PubMed Web of Science ®Google Scholar
• Didem T, Faruk T, Senem K, Derya D, Murat S, Murat G, Oznur K. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer. Tumour Biol 2014; 35:6777-82; PMID:24722824; http://dx.doi.org/10.1007/s13277-014-1923-z
   PubMedGoogle Scholar
• Tastekin D, Tas F, Karabulut S, Duranyildiz D, Serilmez M, Guveli M, Vatansever S. Clinical significance of serum tenascin-C levels in breast cancer. Tumour Biol 2014; 35:6619-25; PMID:24696262; http://dx.doi.org/10.1007/s13277-014-1875-3
   PubMedGoogle Scholar
• Schenk S, Muser J, Vollmer G, Chiquet-Ehrismann R. Tenascin-C in serum: a questionable tumor marker. Int J Cancer 1995; 61:443-9; PMID:7538974; http://dx.doi.org/10.1002/ijc.2910610402
   PubMedGoogle Scholar
• Takeda A, Otani Y, Iseki H, Takeuchi H, Aikawa K, Tabuchi S, Shinozuka N, Saeki T, Okazaki Y, Koyama I. Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer. World J Surg 2007; 31:388-94; PMID:17219282; http://dx.doi.org/10.1007/s00268-006-0328-6
   PubMedGoogle Scholar
• Takeda A, Otani Y, Hirooka E, Okada K, Torii T, Shinozuka N, Koyama I. Plasma large Tenascin-C spliced variant as a possible biomarker for the prediction of hepatic recurrence in colorectal cancer. Surgery 2007; 141:124-5; PMID:17188181; http://dx.doi.org/10.1016/j.surg.2006.07.044
   PubMedGoogle Scholar
• Richter P, Tost M, Franz M, Altendorf-Hofmann A, Junker K, Borsi L, Neri D, Kosmehl H, Wunderlich H, Berndt A. B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? J Cancer Res Clin Oncol 2009; 135:1351-8; PMID:19326143; http://dx.doi.org/10.1007/s00432-009-0576-6
   PubMedGoogle Scholar
• Gecks T, Junker K, Franz M, Richter P, Walther M, Voigt A, Neri D, Kosmehl H, Wunderlich H, Kiehntopf M, et al. B domain containing Tenascin-C: a new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder? Clin Chim Acta 2011; 412:1931-6; PMID:21763295; http://dx.doi.org/10.1016/j.cca.2011.06.038
   PubMed Web of Science ®Google Scholar
• Brellier F, Martina E, Degen M, Heuze-Vourc'h N, Petit A, Kryza T, Courty Y, Terracciano L, Ruiz C, Chiquet-Ehrismann R. Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors. BMC Clin Pathol 2012; 12:14; PMID:22947174; http://dx.doi.org/10.1186/1472-6890-12-14
   PubMedGoogle Scholar
• Akabani G, Reardon DA, Coleman RE, Wong TZ, Metzler SD, Bowsher JE, Barboriak DP, Provenzale JM, Greer KL, DeLong D, et al. Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study. J Nucl Med 2005; 46:1042-51; PMID:15937318
   PubMed Web of Science ®Google Scholar
• Cokgor I, Akabani G, Kuan CT, Friedman HS, Friedman AH, Coleman RE, McLendon RE, Bigner SH, Zhao XG, Garcia-Turner AM, et al. Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. Jo Clin Oncol 2000; 18:3862-72; PMID:11078500
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011; 10:767-77; PMID:21921921; http://dx.doi.org/10.1038/nrd3554
   PubMed Web of Science ®Google Scholar
• Brack SS, Silacci M, Birchler M, Neri D. Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res 2006; 12:3200-8; PMID:16707621; http://dx.doi.org/10.1158/1078-0432.CCR-05-2804
   PubMed Web of Science ®Google Scholar
• Pedretti M, Verpelli C, Marlind J, Bertani G, Sala C, Neri D, Bello L. Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. Br J Cancer 2010; 103:827-36; PMID:20736949; http://dx.doi.org/10.1038/sj.bjc.6605832
   PubMed Web of Science ®Google Scholar
• Saghizadeh M, Khin HL, Bourdon MA, Kenney MC, Ljubimov AV. Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas. Cornea 1998; 17:326-32; PMID:9603390; http://dx.doi.org/10.1097/00003226-199805000-00014
   PubMed Web of Science ®Google Scholar
• Ljubimov AV, Saghizadeh M, Spirin KS, Khin HL, Lewin SL, Zardi L, Bourdon MA, Kenney MC. Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci 1998; 39:1135-42; PMID:9620072
   PubMed Web of Science ®Google Scholar
• Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-β. EMBO J 1988; 7:2977-82; PMID:2460335
   PubMed Web of Science ®Google Scholar
• Chimal-Monroy J, Diaz de Leon L. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol 1999; 43:59-67; PMID:10213083
   PubMed Web of Science ®Google Scholar
• Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biophys Acta 2009; 1793:888-92; PMID:19162090; http://dx.doi.org/10.1016/j.bbamcr.2008.12.012
   PubMed Web of Science ®Google Scholar
• Akhurst RJ, Lehnert SA, Faissner A, Duffie E. TGF β in murine morphogenetic processes: the early embryo and cardiogenesis. Development 1990; 108:645-56; PMID:1696875
   PubMed Web of Science ®Google Scholar
• Soini Y, Kamel D, Apaja-Sarkkinen M, Virtanen I, Lehto VP. Tenascin immunoreactivity in normal and pathological bone marrow. J Clin Pathol 1993; 46:218-21; PMID:7681854; http://dx.doi.org/10.1136/jcp.46.3.218
   PubMed Web of Science ®Google Scholar
• Suzuki S, Li AJ, Ikemoto M, Imamura T. Expression of tenascin-C long isoforms is induced in the hypothalamus by FGF-1. Neuroreport 2002; 13:1041-5; PMID:12060805; http://dx.doi.org/10.1097/00001756-200206120-00013
   PubMedGoogle Scholar
• Latijnhouwers MA, de Jongh GJ, Bergers M, de Rooij MJ, Schalkwijk J. Expression of tenascin-C splice variants by human skin cells. Arch Dermatol Res 2000; 292:446-54; PMID:11000288; http://dx.doi.org/10.1007/s004030000152
   PubMedGoogle Scholar
• Borsi L, Balza E, Gaggero B, Allemanni G, Zardi L. The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J Biol Chem 1995; 270:6243-5; PMID:7534307; http://dx.doi.org/10.1074/jbc.270.11.6243
   PubMed Web of Science ®Google Scholar
• Borsi L, Allemanni G, Gaggero B, Zardi L. Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells. Int J Cancer 1996; 66:632-5; PMID:8647625; http://dx.doi.org/10.1002/(SICI)1097-0215(19960529)66:5%3c632::AID-IJC9%3e3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Bumke MA, Neri D, Elia G. Modulation of gene expression by extracellular pH variations in human fibroblasts: a transcriptomic and proteomic study. Proteomics 2003; 3:675-88; PMID:12748947; http://dx.doi.org/10.1002/pmic.200300395
   PubMedGoogle Scholar
• Jensen MA, Wilkinson JE, Krainer AR. Splicing factor SRSF6 promotes hyperplasia of sensitized skin. Nat Struct Mol Biol 2014; 21:189-97; PMID:24440982; http://dx.doi.org/10.1038/nsmb.2756
   PubMed Web of Science ®Google Scholar
• Taylor HC, Lightner VA, Beyer WF Jr., McCaslin D, Briscoe G, Erickson HP. Biochemical and structural studies of tenascin/hexabrachion proteins. J Cell Biochem 1989; 41:71-90; PMID:2482292; http://dx.doi.org/10.1002/jcb.240410204
   PubMedGoogle Scholar
• Kammerer RA, Schulthess T, Landwehr R, Lustig A, Fischer D, Engel J. Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil α-helices. J Biol Chem 1998; 273:10602-8; PMID:9553121; http://dx.doi.org/10.1074/jbc.273.17.10602
   PubMed Web of Science ®Google Scholar
• Redick SD, Schwarzbauer JE. Rapid intracellular assembly of tenascin hexabrachions suggests a novel cotranslational process. J Cell Sci 1995; 108(Pt 4):1761-9; PMID:7542260
   PubMed Web of Science ®Google Scholar
• Erickson HP, Inglesias JL. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 1984; 311:267-9; PMID:6482952; http://dx.doi.org/10.1038/311267a0
   PubMed Web of Science ®Google Scholar
• Luczak JA, Redick SD, Schwarzbauer JE. A single cysteine, Cys-64, is essential for assembly of tenascin-C hexabrachions. J Biol Chem 1998; 273:2073-7; PMID:9442046; http://dx.doi.org/10.1074/jbc.273.4.2073
   PubMedGoogle Scholar
• Gupta R, Jung E, Brunak S. Prediction of N-glycosylation sites in human proteins. (in preparation 2004).
   Google Scholar
• Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 2013; 32:1478-88; PMID:23584533; http://dx.doi.org/10.1038/emboj.2013.79
   PubMed Web of Science ®Google Scholar
• Vaughan L, Huber S, Chiquet M, Winterhalter KH. A major, six-armed glycoprotein from embryonic cartilage. EMBO J 1987; 6:349-53; PMID:3582363
   PubMed Web of Science ®Google Scholar
• Sano K, Asanuma-Date K, Arisaka F, Hattori S, Ogawa H. Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration. Glycobiology 2007; 17:784-94; PMID:17369286; http://dx.doi.org/10.1093/glycob/cwm031
   PubMedGoogle Scholar
• Jones GE, Arumugham RG, Tanzer ML. Fibronectin glycosylation modulates fibroblast adhesion and spreading. J Cell Biol 1986; 103:1663-70; PMID:2946699; http://dx.doi.org/10.1083/jcb.103.5.1663
   PubMedGoogle Scholar
• Sano K, Miyamoto Y, Kawasaki N, Hashii N, Itoh S, Murase M, Date K, Yokoyama M, Sato C, Kitajima K, et al. Survival signals of hepatic stellate cells in liver regeneration are regulated by glycosylation changes in rat vitronectin, especially decreased sialylation. J Biol Chem 2010; 285:17301-9; PMID:20335177; http://dx.doi.org/10.1074/jbc.M109.077016
   PubMedGoogle Scholar
• Alisson-Silva F, Freire-de-Lima L, Donadio JL, Lucena MC, Penha L, Sa-Diniz JN, Dias WB, Todeschini AR. Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. PloS One 2013; 8:e60471; PMID:23593224; http://dx.doi.org/10.1371/journal.pone.0060471
   PubMedGoogle Scholar
• Kasbaoui L, Harb J, Bernard S, Meflah K. Differences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressiveness. Cancer Res 1989; 49:5317-22; PMID:2766300
   PubMed Web of Science ®Google Scholar
• Chung CY, Erickson HP. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. J Cell Sci 1997; 110(Pt 12):1413-9; PMID:9217327
   PubMed Web of Science ®Google Scholar
• Ramos DM, Chen B, Regezi J, Zardi L, Pytela R. Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 1998; 75:680-7; PMID:9495234; http://dx.doi.org/10.1002/(SICI)1097-0215(19980302)75:5%3c680::AID-IJC4%3e3.0.CO;2-V
   PubMed Web of Science ®Google Scholar
• Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci 1999; 40:1071-80; PMID:10235540
   PubMed Web of Science ®Google Scholar
• Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 2010; 285:2028-39; PMID:19887451; http://dx.doi.org/10.1074/jbc.M109.051961
   PubMed Web of Science ®Google Scholar
• Rocco M, Carson M, Hantgan R, McDonagh J, Hermans J. Dependence of the shape of the plasma fibronectin molecule on solvent composition. Ionic strength and glycerol content. J Biol Chem 1983; 258:14545-9; PMID:6643501
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell 1988; 53:383-90; PMID:2452695; http://dx.doi.org/10.1016/0092-8674(88)90158-4
   PubMed Web of Science ®Google Scholar
• Hoffman S, Edelman GM. A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. Proc Nat Acad Sci U S A 1987; 84:2523-7; PMID:2436234; http://dx.doi.org/10.1073/pnas.84.8.2523
   PubMed Web of Science ®Google Scholar
• Ruggiero S, Cosgarea R, Potempa J, Potempa B, Eick S, Chiquet M. Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C. Biochimi Biophys Acta 2013; 1832:517-26; PMID:23313574; http://dx.doi.org/10.1016/j.bbadis.2013.01.003
   PubMed Web of Science ®Google Scholar
• Wallner K, Li C, Shah PK, Wu KJ, Schwartz SM, Sharifi BG. EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24:1416-21; PMID:15178565; http://dx.doi.org/10.1161/01.ATV.0000134299.89599.53
   PubMedGoogle Scholar
• Chiao YA, Zamilpa R, Lopez EF, Dai Q, Escobar GP, Hakala K, Weintraub ST, Lindsey ML. In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics. J Proteome Res 2010; 9:2649-57; PMID:20232908; http://dx.doi.org/10.1021/pr100147r
   PubMed Web of Science ®Google Scholar
• Zamilpa R, Lopez EF, Chiao YA, Dai Q, Escobar GP, Hakala K, Weintraub ST, Lindsey ML. Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics 2010; 10:2214-23; PMID:20354994; http://dx.doi.org/10.1002/pmic.200900587
   PubMed Web of Science ®Google Scholar
• Gueders MM, Hirst SJ, Quesada-Calvo F, Paulissen G, Hacha J, Gilles C, Gosset P, Louis R, Foidart JM, Lopez-Otin C, et al. Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2010; 43:286-95; PMID:19843707; http://dx.doi.org/10.1165/rcmb.2008-0426OC
   PubMedGoogle Scholar
• Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, Duffin KL. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008; 58:2420-31; PMID:18668564; http://dx.doi.org/10.1002/art.23654
   PubMed Web of Science ®Google Scholar
• Sofat N, Robertson SD, Hermansson M, Jones J, Mitchell P, Wait R. Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol Int 2012; 32:2809-17; PMID:21874326; http://dx.doi.org/10.1007/s00296-011-2067-8
   PubMed Web of Science ®Google Scholar
• To WS, Midwood KS. Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. Matrix Biol 2010; 29:573-85; PMID:20708078; http://dx.doi.org/10.1016/j.matbio.2010.08.003
   PubMedGoogle Scholar
• Ambort D, Brellier F, Becker-Pauly C, Stocker W, Andrejevic-Blant S, Chiquet M, Sterchi EE. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading. Matrix Biol 2010; 29:31-42; PMID:19748582; http://dx.doi.org/10.1016/j.matbio.2009.08.007
   PubMedGoogle Scholar
• Iyer AK, Tran KT, Borysenko CW, Cascio M, Camacho CJ, Blair HC, Bahar I, Wells A. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol 2007; 211:748-58; PMID:17311283; http://dx.doi.org/10.1002/jcp.20986
   PubMedGoogle Scholar
• Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 2001; 154:459-68; PMID:11470832; http://dx.doi.org/10.1083/jcb.200103103
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 2013; 19:1972-83; PMID:23541003; http://dx.doi.org/10.1089/ten.tea.2012.0568
   PubMed Web of Science ®Google Scholar
• De Laporte L, Rice JJ, Tortelli F, Hubbell JA. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PloS One 2013; 8:e62076; PMID:23637968; http://dx.doi.org/10.1371/journal.pone.0062076
   PubMedGoogle Scholar
• Schumacher S, Stube EM. Regulated binding of the fibrinogen-like domains of tenascin-R and tenascin-C to the neural EGF family member CALEB. J Neurochem 2003; 87:1213-23; PMID:14622101; http://dx.doi.org/10.1046/j.1471-4159.2003.02112.x
   PubMedGoogle Scholar
• Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 2010; 184:2655-62; http://dx.doi.org/10.4049/jimmunol.0903359
   PubMed Web of Science ®Google Scholar
• Latijnhouwers MA, Pfundt R, de Jongh GJ, Schalkwijk J. Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol 1998; 17:305-16; PMID:9749946; http://dx.doi.org/10.1016/S0945-053X(98)90083-X
   PubMed Web of Science ®Google Scholar
• Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. J Invest Dermatol 2006; 126:551-60; PMID:16374482; http://dx.doi.org/10.1038/sj.jid.5700090
   PubMed Web of Science ®Google Scholar
• Nakoshi Y, Hasegawa M, Sudo A, Yoshida T, Uchida A. Regulation of tenascin-C expression by tumor necrosis factor-α in cultured human osteoarthritis chondrocytes. J Rheumatol 2008; 35:147-52; PMID:18061975
   PubMed Web of Science ®Google Scholar
• Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 2004; 23:1656-67; PMID:15001984; http://dx.doi.org/10.1038/sj.onc.1207064
   PubMed Web of Science ®Google Scholar
• Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 2006; 206:718-27; PMID:16245312; http://dx.doi.org/10.1002/jcp.20527
   PubMedGoogle Scholar
• Yamamoto K, Dang QN, Kennedy SP, Osathanondh R, Kelly RA, Lee RT. Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species. J Biol Chem 1999; 274:21840-6; PMID:10419501; http://dx.doi.org/10.1074/jbc.274.31.21840
   PubMedGoogle Scholar
• Asparuhova MB, Ferralli J, Chiquet M, Chiquet-Ehrismann R. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. FASEB J 2011; 25:3477-88; PMID:21705668; http://dx.doi.org/10.1096/fj.11-187310
   PubMedGoogle Scholar
• Scherer C, Pfisterer L, Wagner AH, Hodebeck M, Cattaruzza M, Hecker M, Korff T. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J Am Heart Assoc 2014; 3:e000626; PMID:24614757; http://dx.doi.org/10.1161/JAHA.113.000626
   PubMedGoogle Scholar
• Jones FS, Chalepakis G, Gruss P, Edelman GM. Activation of the cytotactin promoter by the homeobox-containing gene Evx-1. Proc Nat Acad Sci U S A 1992; 89:2091-5; PMID:1372434; http://dx.doi.org/10.1073/pnas.89.6.2091
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Tannheimer M, Koch M, Brunner A, Spring J, Martin D, Baumgartner S, Chiquet M. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994; 127:2093-101; PMID:7528751; http://dx.doi.org/10.1083/jcb.127.6.2093
   PubMedGoogle Scholar
• Gherzi R, Carnemolla B, Siri A, Ponassi M, Balza E, Zardi L. Human tenascin gene. Structure of the 5'-region, identification, and characterization of the transcription regulatory sequences. J Biol Chem 1995; 270:3429-34; PMID:7531707; http://dx.doi.org/10.1074/jbc.270.7.3429
   PubMedGoogle Scholar
• Copertino DW, Edelman GM, Jones FS. Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. Proc Nat Acad Sci U S A 1997; 94:1846-51; PMID:9050867; http://dx.doi.org/10.1073/pnas.94.5.1846
   PubMedGoogle Scholar
• Gherzi R, Briata P, Boncinelli E, Ponassi M, Querze G, Viti F, Corte G, Zardi L. The human homeodomain protein OTX2 binds to the human tenascin-C promoter and trans-represses its activity in transfected cells. DNA Cell Biol 1997; 16:559-67; PMID:9174161; http://dx.doi.org/10.1089/dna.1997.16.559
   PubMed Web of Science ®Google Scholar
• Mettouchi A, Cabon F, Montreau N, Dejong V, Vernier P, Gherzi R, Mercier G, Binetruy B. The c-Jun-induced transformation process involves complex regulation of tenascin-C expression. Mol Cell Biol 1997; 17:3202-9; PMID:9154819
   PubMed Web of Science ®Google Scholar
• Jones PL, Jones FS, Zhou B, Rabinovitch M. Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. J Cell Sci 1999; 112(Pt 4):435-45; PMID:9914156
   PubMed Web of Science ®Google Scholar
• Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 1999; 18:7755-64; PMID:10618716; http://dx.doi.org/10.1038/sj.onc.1203360
   PubMedGoogle Scholar
• Jones FS, Meech R, Edelman DB, Oakey RJ, Jones PL. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease. Circ Res 2001; 89:131-8; PMID:11463719; http://dx.doi.org/10.1161/hh1401.093582
   PubMedGoogle Scholar
• McKean DM, Sisbarro L, Ilic D, Kaplan-Alburquerque N, Nemenoff R, Weiser-Evans M, Kern MJ, Jones PL. FAK induces expression of Prx1 to promote tenascin-C-dependent fibroblast migration. J Cell Biol 2003; 161:393-402; PMID:12741393; http://dx.doi.org/10.1083/jcb.jcb.200302126
   PubMed Web of Science ®Google Scholar
• Ghatnekar A, Trojanowska M. GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. Biochimi Biophys Acta 2008; 1779:145-51; PMID:18177748; http://dx.doi.org/10.1016/j.bbagrm.2007.11.012
   PubMedGoogle Scholar
• Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC, Zweifel C, Tolnay M, Wasner M, Mergenthaler S, et al. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res 2009; 69:458-65; PMID:19147558; http://dx.doi.org/10.1158/0008-5472.CAN-08-2610
   PubMedGoogle Scholar
• Erickson HP, Taylor HC. Hexabrachion proteins in embryonic chicken tissues and human tumors. J Cell Biol 1987; 105:1387-94; PMID:3654758; http://dx.doi.org/10.1083/jcb.105.3.1387
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Spring J, Ballmer-Hofer K, Hofer U, Chiquet-Ehrismann R. Differential expression of tenascin splicing variants in the chick gizzard and in cell cultures. Cell Differ Dev 1990; 32:417-23; PMID:1711921; http://dx.doi.org/10.1016/0922-3371(90)90058-5
   PubMedGoogle Scholar
• Koch M, Wehrle-Haller B, Baumgartner S, Spring J, Brubacher D, Chiquet M. Epithelial synthesis of tenascin at tips of growing bronchi and graded accumulation in basement membrane and mesenchyme. Exp Cell Res 1991; 194:297-300; PMID:1709104; http://dx.doi.org/10.1016/0014-4827(91)90368-5
   PubMedGoogle Scholar
• Probstmeier R, Martini R, Tacke R, Schachner M. Expression of the adhesion molecules L1, N-CAM and J1/tenascin during development of the murine small intestine. Differentiation 1990; 44:42-55; PMID:1701406; http://dx.doi.org/10.1111/j.1432-0436.1990.tb00535.x
   PubMedGoogle Scholar
• Zhao Y, Young SL. Tenascin in rat lung development: in situ localization and cellular sources. Am J Physiol 1995; 269:L482-91; PMID:7485520
   PubMed Web of Science ®Google Scholar
• LaFleur DW, Fagin JA, Forrester JS, Rubin SA, Sharifi BG. Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. J Biol Chem 1994; 269:20757-63; PMID:7519614
   PubMed Web of Science ®Google Scholar
• Talts JF, Eng H, Zhang HY, Faissner A, Ekblom P. Characterization of monoclonal antibodies against tenascin-C: no apparent effect on kidney development in vitro. Int J Dev Biol 1997; 41:39-48; PMID:9074936
   PubMed Web of Science ®Google Scholar
• Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983; 43:2796-805; PMID:6342760
   PubMed Web of Science ®Google Scholar
• Aukhil I, Joshi P, Yan Y, Erickson HP. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem 1993; 268:2542-53; PMID:7679097
   PubMed Web of Science ®Google Scholar
• Carnemolla B, Borsi L, Bannikov G, Troyanovsky S, Zardi L. Comparison of human tenascin expression in normal, simian-virus-40-transformed and tumor-derived cell lines. Eur J Biochem 1992; 205:561-7; PMID:1374030
   PubMedGoogle Scholar
• Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L. Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 1993; 332:39-43; PMID:7691659; http://dx.doi.org/10.1016/0014-5793(93)80479-E
   PubMedGoogle Scholar
• Ibrahim SN, Lightner VA, Ventimiglia JB, Ibrahim GK, Walther PJ, Bigner DD, Humphrey PA. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol 1993; 24:982-9; PMID:7504654; http://dx.doi.org/10.1016/0046-8177(93)90112-T
   PubMedGoogle Scholar
• Wilson KE, Langdon SP, Lessells AM, Miller WR. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br J Cancer 1996; 74:999-1004; PMID:8855965; http://dx.doi.org/10.1038/bjc.1996.480
   PubMedGoogle Scholar
• Vollmer G, Tan MI, Wunsche W, Frank K. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-β. Biochem Cell Biol 1997; 75:759-69; PMID:9599665
   PubMed Web of Science ®Google Scholar
• Kusagawa H, Onoda K, Namikawa S, Yada I, Okada A, Yoshida T, Sakakura T. Expression and degeneration of tenascin-C in human lung cancers. Br J Cancer 1998; 77:98-102; PMID:9459152; http://dx.doi.org/10.1038/bjc.1998.15
   PubMed Web of Science ®Google Scholar
• Ghert MA, Jung ST, Qi W, Harrelson JM, Erickson HP, Block JA, Scully SP. The clinical significance of tenascin-C splice variant expression in chondrosarcoma. Oncology 2001; 61:306-14; PMID:11721178; http://dx.doi.org/10.1159/000055338
   PubMedGoogle Scholar
• Levy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P, et al. Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res 2007; 13:398-407; PMID:17202312; http://dx.doi.org/10.1158/1078-0432.CCR-06-0182
   PubMed Web of Science ®Google Scholar
• Paasinen-Sohns A, Kaariainen E, Yin M, Jarvinen K, Nummela P, Holtta E. Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase. Int J Biochem Cell Biol 2011; 43:441-54; PMID:21134486; http://dx.doi.org/10.1016/j.biocel.2010.11.018
   PubMedGoogle Scholar
• Sakai T, Kawakatsu H, Hirota N, Yokoyama T, Takoka T, Sakakura T, Saito M. Tenascin expression in vitro and in vivo: comparison between epithelial and nonepithelial rat cell lines. Exp Cell Res 1993; 206:244-54; PMID:7684694; http://dx.doi.org/10.1006/excr.1993.1144
   PubMedGoogle Scholar
• Dang C, Gottschling M, Roewert J, Forschner T, Stockfleth E, Nindl I. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 2006; 155:763-70; PMID:16965426; http://dx.doi.org/10.1111/j.1365-2133.2006.07401.x
   PubMedGoogle Scholar
• Katz S, Hukkanen M, Lounatmaa K, Rousselle P, Tervo T, Virtanen I. Cooperation of isoforms of laminin-332 and tenascin-CL during early adhesion and spreading of immortalized human corneal epithelial cells. Exp Eye Res 2006; 83:1412-22; PMID:16963023; http://dx.doi.org/10.1016/j.exer.2006.07.021
   PubMedGoogle Scholar
• Tseleni-Balafouta S, Gakiopoulou H, Fanourakis G, Voutsinas G, Balafoutas D, Patsouris E. Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma. Exp Mol Pathol 2006; 80:177-82; PMID:16259977; http://dx.doi.org/10.1016/j.yexmp.2005.09.006
   PubMedGoogle Scholar
• Frey K, Fiechter M, Schwager K, Belloni B, Barysch MJ, Neri D, Dummer R. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Exp Dermatol 2011; 20:685-8; PMID:21649738; http://dx.doi.org/10.1111/j.1600-0625.2011.01314.x
   PubMed Web of Science ®Google Scholar
• Galler K, Junker K, Franz M, Hentschel J, Richter P, Gajda M, Gohlert A, von Eggeling F, Heller R, Giavazzi R, et al. Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery. Histochem Cell Biol 2012; 137:195-204; PMID:22075565; http://dx.doi.org/10.1007/s00418-011-0886-z
   PubMedGoogle Scholar
• Nies DE, Hemesath TJ, Kim JH, Gulcher JR, Stefansson K. The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem 1991; 266:2818-23; PMID:1704365
   PubMed Web of Science ®Google Scholar